Prescribing intelligence for ADHD therapies

Prescriptions for CNS stimulants to treat ADHD are increasing. In England there was a 9% growth in patient numbers mid-2017 to mid-2018, with over a million prescription items issued, predominantly to males aged 7-18.
Medications are grouped into 12 hour or 8 hour modified release methylphenidate, immediate release methylphenidate, Lisdexamfetamine, Atomoxetine and Guafacine. 
The RxIndex below monitors the performance of all modified release methylphenidate brands, the most frequently prescribed drugs for ADHD.



ADHD specific resources coming soon!

Further Resources:

Other industry sectors Free useful downloads